In this edition of Ideas for Profit, Moneycontrol's Sakshi Batra explains what makes this vaccine candidate a worthy investment bet even after the fading of the HCQS opportunity
first published: Sep 25, 2020 03:55 pm
A collection of the most-viewed Moneycontrol videos.

Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live

Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live

Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live

Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
Is it a good time to enter Bajaj Finance post Q3 business update? | Opening Bell
Attractive valuation, strong earnings potential: Buy this stock for the long term | Ideas for Profit

Vesuvius India made fresh lifetime high. Right time to buy the stock or wait for a drop?

Indian Hotel Industry Sees Strong Demand; Buy This Stock For Sector Upcycle | Ideas For Profit
Can strong auto demand drive this company’s stock further? | Ideas For Profit
You are already a Moneycontrol Pro user.

